Core Viewpoint - Lifeway Foods, Inc. expresses strong opposition to the nomination of George Sent and Edward Smolyansky for the Board of Directors, citing their questionable backgrounds and potential risks to shareholder value [1][2][3]. Group 1: Dissident Nominees' Background and Concerns - The Dissident Nominees have ethical concerns and a track record that suggests they are unfit for the Board [2]. - George Sent's previous role as Lifeway's Lead Independent Director raises questions about his alignment with the Dissident, indicating a troubling reversal of principle [3]. - Edward Smolyansky's personal financial issues and those of his mother, Ludmila Smolyansky, may be driving their push for a quick sale of Lifeway at any price, which could conflict with the interests of other shareholders [4][5]. Group 2: Financial and Operational Performance - Lifeway has achieved a total shareholder return of 788% over the past five years, significantly outperforming peers and the S&P 500 [10]. - The company reported a 29% increase in net sales for Q3 2025, reaching $57.1 million, driven by its flagship product, Lifeway Kefir [10]. - Lifeway's gross margin expanded by 300 basis points, and net income grew by 19%, reflecting effective operational execution [10]. Group 3: Board Composition and Governance - Lifeway's Board is committed to thoughtful refreshment, replacing long-serving directors and adding new independent members to enhance governance [10][11]. - The dissident group has not presented a compelling case for change or a clear plan for governance and operational improvement [10]. - New independent board members have been appointed, bringing expertise in business growth, accounting, and corporate governance [14].

Core Viewpoint - The company is urging shareholders to vote for the GREEN Universal Proxy Card to facilitate significant changes in the board structure, addressing long-standing governance issues and leadership practices that have negatively impacted shareholder value [1][3][16]. Group 1: Shareholder Engagement and Governance Changes - The company, led by Edward Smolyansky and co-founder Ludmila Smolyansky, holds a significant 26.17% ownership stake in Lifeway Foods, Inc. [2] - A Cooperation Agreement with Danone North America PBC has been established, which includes governance changes such as separating the CEO and Chair roles and adding four new independent directors to the board [3][4]. - Concerns have been raised that the Cooperation Agreement may not sufficiently ensure a well-constituted board, as some legacy directors may prioritize self-preservation over long-term value creation [4][16]. Group 2: Board Composition and Nomination - The company has nominated two qualified candidates, George Sent and Edward Smolyansky, for board positions, emphasizing their relevant industry experience and institutional knowledge [5]. - A proposal is being made to establish a Strategy and Performance Committee composed solely of new independent directors to evaluate management and corporate strategy [6]. Group 3: Historical Context and Governance Failures - Danone's previous offers to acquire Lifeway at $25 and later $27 per share, representing a 72% premium, were rejected by the board, leading to legal disputes and governance concerns [7]. - The board's lack of a clear strategy to enhance share price has raised questions about management effectiveness and alignment with shareholder interests [7]. - Legacy directors have been criticized for self-dealing, including excessive CEO compensation and questionable stock sales, which have eroded shareholder trust [8][10]. Group 4: Ongoing Governance Issues - Despite the Cooperation Agreement, governance failures persist, as evidenced by the extension of a poison pill strategy that may deter credible acquisition interest [11]. - The company has faced criticism for its communication practices, which appear to align closely with the CEO's interests rather than independent evaluation [12]. - Delays in scheduling the 2025 annual meeting and failure to provide customary notice have raised further governance concerns [14].

Core Viewpoint - Lifeway Foods, Inc. expresses strong opposition to the nomination of Edward Smolyansky and George Sent for the Board of Directors, citing serious ethical concerns and potential risks to shareholder value due to the nominees' backgrounds and personal financial issues [1][2][4][8]. Group 1: Dissident Nominees' Background - The track record of the Dissident Nominees raises significant ethical concerns, indicating they may be unfit to serve on the Board [2][8]. - George Sent's previous role as Lifeway's Lead Independent Director and his alignment with the Dissident is viewed as a troubling reversal of principle [3][8]. - The Dissident, Edward Smolyansky, has a history of misconduct, including being terminated for cause and defaulting on a $10.4 million mortgage [7][5]. Group 2: Financial Distress and Shareholder Interests - Edward and Ludmila Smolyansky's personal financial distress may be driving their push for a quick sale of Lifeway, potentially compromising the interests of other shareholders [4][5]. - The Smolyanskys have sold over 2.5 million shares of Lifeway stock in the last five years, with no purchases made, raising concerns about their commitment to the company [6][8]. Group 3: Company Performance and Governance - Lifeway has demonstrated strong financial performance, with a 788% total shareholder return over the past five years and a 29% increase in net sales in Q3 2025 [12][10]. - The Board is committed to refreshing its membership thoughtfully, aiming to enhance independence and effectiveness [11][14]. - Institutional Shareholder Services (ISS) has advised shareholders to reject the proposals from the Dissident group, indicating a lack of compelling case for change [9][12].

Core Viewpoint - Lifeway Foods has entered into a Cooperation Agreement with Danone North America, which includes a board refreshment plan and a stay on pending litigation related to the Stockholders' Agreement, aimed at maximizing shareholder value and ensuring good governance practices [1][3][4]. Board Refreshment - Lifeway will appoint three independent directors by October 30, 2025, and one additional independent director by November 14, 2025, selected by the Board's Strategic Review Committee [4]. - The roles of Chair and CEO will be separated by the earlier of October 30, 2025, or the appointment of the third new independent director, with an independent director appointed as Chair [4]. - Current board members Pol Sikar and Jay Scher will step down by the 2025 and 2026 annual meetings, respectively [4]. Litigation and Stockholders' Agreement - Lifeway and Danone have agreed to jointly stay pending litigation related to the Stockholders' Agreement [4]. - Lifeway will comply with the Stockholders' Agreement without contesting its validity, while Danone waives certain rights under the agreement, including the right to appoint a board member [4]. Future Solicitations and Compensation - Danone will support the Board's recommendations regarding board composition and organizational documents if a special meeting or consent solicitation is called by Edward or Ludmila Smolyansky before June 30, 2026 [4]. - Lifeway's Compensation Committee is permitted to issue equity-based compensation to management, excluding Julie Smolyansky and her relatives, to attract and retain talent [4]. Capital Allocation and Growth - Lifeway is evaluating capital allocation alternatives to maximize shareholder value in light of the changes from the Cooperation Agreement [3]. - Julie Smolyansky, CEO, emphasized the importance of resilience, innovation, and community in moving forward with the agreement to enhance growth and shareholder value [5].

Company Overview - Lifeway Foods, Inc. is a leading U.S. supplier of kefir and fermented probiotic products, recognized as one of Forbes' Best Small Companies [4] - The company offers a variety of products including drinkable kefir, cheeses, and a ProBugs line for children, with sales across multiple countries [4] Financial Performance - Lifeway achieved gross sales exceeding $5 million for the week ending April 27, 2025, marking a 35% increase compared to the same week in the previous year [1] - The company is set to report its financial results for the first quarter ended March 31, 2025, on May 13, 2025, before market hours [2] Communication and Investor Relations - A pre-recorded conference call and webcast featuring Julie Smolyanksy, Lifeway's President and CEO, will be available on the company's website following the release of the first quarter results [3]